Successful Treatment of Enterocutaneous Fistula in a Hemodialysis Patient with Somatostatin

Although cysticercosis is the most common parasitic disease affecting the central nervous system, spinal cysticercosis is rare. A rare form of spinal cysticercosis involving the whole spinal canal is presented. A 45-year-old Korean male had a history of intracranial cysticercosis and showed progressive paraparesis. Spinal magnetic resonance scan showed multiple cysts compressing the spinal cord from C1 to L1. Three different levels (C1-2, T1-3, and T11-L1) required operation. Histopathological examination confirmed cysticercosis. The patient improved markedly after surgery.

[1]  H. Reber,et al.  Complicated Enterocutaneous Fistulas: Failure of Octreotide to Improve Healing , 2000, World Journal of Surgery.

[2]  J. Spiliotis,et al.  Treatment of enterocutaneous fistulas with TPN and somatostatin, compared with patients who received TPN only , 1990, The British journal of clinical practice.

[3]  K. Sirinek,et al.  Chronic renal failure: effect of hemodialysis on gastrointestinal hormones. , 1984, American journal of surgery.

[4]  K. Karayalçın,et al.  Treatment of external biliary, pancreatic and intestinal fistulas with a somatostatin analog. , 1994, Digestive diseases.

[5]  F. Keller,et al.  Somatostatin-induced hyperkalemia in a patient on maintenance hemodialysis. , 1991, Nephron.

[6]  A. Parmeggiani,et al.  Human pancreatic polypeptide and somatostatin in chronic renal failure. , 1985, Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress.